Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate. - Wikidata - wikimedia - TriplyDB

Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.

Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.

http://www.wikidata.org/entity/Q37992162

about

An Updated Overview on Therapeutic Drug Monitoring of Recent Antiepileptic Drugs Neuroprotective Effect of Lacosamide on Hypoxic-Ischemic Brain Injury in Neonatal Rats.Chiral chromatographic resolution of antiepileptic drugs and their metabolites: a challenge from the optimization to the application.New developments in the treatment of partial-onset epilepsy.AMPA receptor inhibitors for the treatment of epilepsy: the role of perampanel.Carbonyl reduction pathways in drug metabolism.Clinical pharmacokinetic and pharmacodynamic profile of lacosamide.Third generation antiepileptic drug monotherapies in adults with epilepsy.New antiepileptic drugs: focus on ezogabine, clobazam, and perampanel.

P2860

Q28069989-F635D0B2-7939-49A7-9EEC-B33CFDE4883D Q33567241-D9FE37F6-791A-4481-9F95-08E1A3D5A66B Q34941977-0B616B59-0C3F-45A8-857B-2948782BD166 Q36337897-5BD768CF-D405-45D0-9444-852BC72CCD48 Q38112213-02ED02D7-389F-44CF-BA46-B7B7C5134094 Q38156452-848783C3-F9C0-41E7-AE35-11F2145F08E7 Q38468591-0444C719-ADC9-40D3-9190-9C885CA8129D Q38849966-D0458B14-A82A-447C-BCFB-63977152D321 Q38851234-63A41A08-5A89-4E10-8C61-E7D43B62F1F4

P2860

Pharmacotherapy of the third-generation AEDs: lacosamide, retigabine and eslicarbazepine acetate.

http://www.wikidata.org/entity/Q37992162

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Pharmacotherapy of the third-g ...... e and eslicarbazepine acetate.

@en

Pharmacotherapy of the third-g ...... e and eslicarbazepine acetate.

@nl

type

label

Pharmacotherapy of the third-g ...... e and eslicarbazepine acetate.

@en

Pharmacotherapy of the third-g ...... e and eslicarbazepine acetate.

@nl

prefLabel

Pharmacotherapy of the third-g ...... e and eslicarbazepine acetate.

@en

Pharmacotherapy of the third-g ...... e and eslicarbazepine acetate.

@nl

P1433

Q37992162-0C0C293A-8CD1-4943-9C41-0D9840633924

P1476

Q37992162-18BEA4CB-C1FB-4F31-898F-632EC0F4BAF3

P2093

Q37992162-3588EBD7-CE65-4DEB-9668-B6270EB4A198

Q37992162-B08D0B3F-AE9E-4EED-92A1-AB45607378AC

P2860

Q37992162-018E5BE8-37C9-441F-BF22-CDBC0C2F997F

Q37992162-05238BF3-A902-4AB4-B833-D24AE43B3244

Q37992162-066A24D2-B1B5-4D8F-97E9-C09A7CA3E66A

Q37992162-08BF682D-13E8-417D-B1DB-5481681F8991

Q37992162-094BC7AD-1656-42CA-B828-B1F75DFD723D

Q37992162-0C823085-2190-4E4D-946E-D5903EBCD5D9

Q37992162-196B6E09-5D20-402D-8D21-5FE20B170086

Q37992162-1A6BBD94-3E9C-4F65-8A4F-DEB1EFCBFE46

Q37992162-1A810D83-1B72-4EF6-BCFB-49BC0D2D511E

Q37992162-1D62E616-A96F-46F0-AFFF-1904938DD4B6

P304

Q37992162-32C68396-6990-4679-8106-03C0085272DA

P31

Q37992162-D68FECBE-576C-47E4-960A-BF589D42EEE1

P356

Q37992162-0246D7BC-0C44-4706-9891-643EAC9CEACA

P407

Q37992162-355873EE-778B-469D-AC86-472BC064CABC

P433

Q37992162-20233074-22AB-490C-A171-42CD4512E1F9

P478

Q37992162-A6D81DB2-CB2A-4061-8DAA-72DC32386509

P577

Q37992162-5F765700-3048-4174-BD17-564E1C035249

P698

Q37992162-96FDDCE3-5C13-4950-B198-D6DCCC97DFFA

P921

Q37992162-7D86DF26-4A62-4B54-BAFB-688DC6E09FB4

P356

14656566.2012.667803

P1433

Expert Opinion on Pharmacotherapy

P1476

Pharmacotherapy of the third-g ...... e and eslicarbazepine acetate.

@en

P2093

David J Berry

http://www.w3.org/2001/XMLSchema#string

Philip N Patsalos

http://www.w3.org/2001/XMLSchema#string

P2860

The novel anticonvulsant retigabine activates M-currents in Chinese hamster ovary-cells tranfected with human KCNQ2/3 subunits

Early identification of refractory epilepsy

Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)

Lacosamide: a new approach to target voltage-gated sodium currents in epileptic disorders

Remission of epilepsy after two drug failures in children: a prospective study.

Multiple-dose, linear, dose-proportional pharmacokinetics of retigabine in healthy volunteers.

Efficacy of intravenous lacosamide in refractory nonconvulsive status epilepticus and simple partial status epilepticus.

Lacosamide for the prevention of partial onset seizures in epileptic adults.

Update on treatment of partial onset epilepsy: role of eslicarbazepine

Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

P304

699-715

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.2012.667803

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P577

2012-03-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22404663

http://www.w3.org/2001/XMLSchema#string

P921

pharmacotherapy